Hints and tips:
...Bristol Myers Squibb told the FT last year it expected to cancel some drug programmes, with cancer medicines most vulnerable....
...Cancer, stroke and diabetes medications made by Merck, Johnson & Johnson and Bristol Myers Squibb are among the first tranche of medications selected for negotiation....
...The company said that the IRA would have deterred development of its Soliris drug, which is now approved to treat four rare diseases....
...Bristol Myers Squibb says it expects to cancel some drug development programmes due to US government drug pricing rules that are due to be phased in from next year....
...from Conor Cruise O’Brien, now in his 90th year, arguably the greatest Irishman of his age, and an implacable foe of violent republicans, there have been journalists such as Ruth Dudley Edwards and Kevin Myers...
International Edition